On Tuesday shares of Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) closed at $6.67. Company’s sales growth for last 5 years was 37.50%. Hedge fund Armistice Capital has taken a 5.4% stake in Spectrum Pharmaceuticals (NASDAQ:SPPI), agitating for sweeping changes in how the biotech does business and demanding it find a buyer on the quick.
Osiris Therapeutics, Inc. (NASDAQ:OSIR) in last trading activity moved up 1.74% to close at $17.52. Company weekly performance is 15.80% while its quarterly performance stands at 17.03%. Osiris Therapeutics, Inc. (NASDAQ:OSIR) is -7.10% away from its 52 week high. Osiris Therapeutics Inc. (NASDAQ:OSIR) on May 08, reported first-quarter net income of $1.4 million, after reporting a loss in the same period a year earlier.
On last trading day Exxon Mobil Corporation (NYSE:XOM) moved up 0.28% to close at $87.02. Its volatility for the week is 1.73% while volatility for the month is 1.44%. XOM’s sales growth for past 5 years was 5.50% and its EPS growth for past 5 years was 13.80%. Exxon Mobil Corporation (NYSE:XOM) monthly performance is 2.81%. Exxon Mobil Corporation (NYSE:XOM) begin trading ex-dividend on May 11, 2015. A cash dividend payment of $0.73 per share is scheduled to be paid on June 10, 2015.
Brixmor Property Group Inc. (NYSE:BRX) has 15.10% insider ownership while its institutional ownership stands at 97.90%. In last trading activity company’s stock closed at $23.97. Brixmor Property Group Inc. (NYSE:BRX) announced that it will release its 2015 second quarter earnings on Monday, July 27, 2015 after the market close. Brixmor will host a teleconference on Tuesday, July 28, 2015 at 10:00 AM ET.
On last trading day Cooper Tire & Rubber Co. (NYSE:CTB) decreased -0.85% to close at $35.95. Its volatility for the week is 2.01% while volatility for the month is 2.55%. CTB’s sales growth for past 5 years was 4.30% and its EPS growth for past 5 years was 17.30%. Cooper Tire & Rubber Co. (NYSE:CTB) monthly performance is -15.07%. Goldman Sachs cut shares of Cooper Tire & Rubber Co (NYSE:CTB) from a neutral rating to a sell rating in a research report sent to investors on Wednesday morning, TheFlyOnTheWall.com reports.